Kratom, derived from the Mitragyna speciosa tree in Southeast Asia, has gained popularity in the U.S. as an unregulated alternative to opioids. While many users report success in reducing pain and dependence on prescription painkillers, there are clear caveats. Surveys indicate that up to half of American kratom users have lessened or stopped opioid use, but experiences with side effects—like withdrawal symptoms and dependency—are frequent. Despite animal research hinting at a lower abuse potential than traditional opioids, health authorities warn of inconsistencies in commercial products, contamination risks, and unknown long-term effects. Experts stress the urgent need for clinical trials, as no official agency currently endorses kratom for medical use. For a detailed look at kratom’s potential and pitfalls, see the original article on Gigwise: Is Kratom a Viable Option Instead of Opioids?.